How GLP-1 Agonists Are Changing Obesity Care with Dr. Spencer Nadolsky

Episode release date
Episode length
01:13:08

Episode shownotes

GLP-1 agonist medications have been a popular topic of discussion recently. While this weight loss drug was designed for obesity, GLP-1 agonists like Ozempic have made their way into Hollywood. This has people questioning their safety and possible health risks, especially in the long run. Are GLP-1 agonists a quick fix for weight loss or a lifetime prescription? Who should be prescribed this medication, and what are the possible side effects? 

This Longevity by Design episode features an interview with Dr. Spencer Nadolskyβ€”An obesity and lipid specialist physician. Dr. Nadolsky explains how GLP-1 medications cause weight loss, answers questions about safety concerns, and discusses interesting patient stories about how people react to this medication. Dr. Nadolsky has a lot of patient experience with GLP-1 agonist drugs and is very knowledgeable about their current use and future potential.

Timestamps:

  • Introduction: (0:00–2:00)
  • Why Dr. Nadolsky became a physician: (2:00–4:13) 
  • What is cardiometabolic medicine?: (4:13–5:17)
  • What is a β€œhealthy” metabolism?: (5:17–7:37)
  • How does diet impact glucose regulation: (7:37–10:20)
  • Why has insulin resistance increased in the past decade?: (10:20–11:45)
  • Ethnicity impacts BMI cutoffs: (11:45–12:57)
  • Is obesity a choice?: (12:57–17:40) 
  • How socioeconomic status impacts obesity: (17:40–21:30)
  • What's better: A BMI score or a DEXA scan?: (21:30–25:33)
  • How strength training improves healthspan: (25:33–32:32) 
  • What a fasting insulin blood test tells you: (32:32–36:58)
  • Health risks of insulin resistance: (35:15–38:08)
  • How insulin resistance can increase ApoB: (38:08–39:25)
  • How does ApoB predict heart disease risk?: (39:25–42:50)
  • Why isn't ApoB included in typical lipid panels?: (42:50–44:25)
  • Behavioral science and clinical practice: (44:25–50:06)
  • How do GLP-1 agonists cause weight loss? (50:06–56:03)
  • Negative side effects of GLP-1 medications: (56:03–57:36)
  • Price of GLP-1s: (57:36–58:53)
  • GLP-1: A short term quick fix or a lifetime prescription?: (58:53–1:02:19)
  • Biggest health myths on social media: (1:02:19–1:08:45)
  • Top tip for healthspan: (1:08:45–end) 


Longevity By Design is produced by InsideTracker. InsideTracker provides a personalized health analysis and data-driven wellness guide to help you add years to your lifeβ€”and life to your years. Choose a plan that best fits your needs to get your comprehensive biomarker analysis, customized action plan, and customer-exclusive healthspan resources.

Listen to all episodes of Longevity By Design at https://info.insidetracker.com/longevitybydesign

The content of this podcast episode was automatically imported from the publicly available RSS feed provided by the creator of the podcast.